On Wednesday, June 12, the Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) held an open seminar at Shinanomachi Campus .

16:00 -17:30 Wednesday, June 12, 2024

“New Technologies and Building Successful Biotechnology Companies to Treat Disease: A Personal History”

Harvey F. Lodish, PhD

Professor of Biology and Professor of Biological Engineering, Massachusetts Institute of Technology
Lead author, “Molecular Cell Biology”
Founder/scientific board member: Genzyme, Millennium Pharmaceuticals, Rubius Therapeutics, Tevard

Prof. Lodish highlighted the connection between academia and entrepreneurship in biotechnology, covering key aspects of starting a biotech company, intellectual property, and assembling a team with diverse expertise. The importance of scientists leveraging their expertise by consulting for or founding companies and the advantage of research institutes being located near biotech companies for collaboration was also discussed.